Hydrocortone ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
78下垂体前葉機能低下症2

78. 下垂体前葉機能低下症


臨床試験数 : 492 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-005018-37-IE
(EUCTR)
18/01/200807/09/2007Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary patients - Optimal glucocorticoid replacementOptimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary patients - Optimal glucocorticoid replacement 10 male patients with hypopituitarism resulting in ACTH (adrenocorticotropin) deficiency (ICD E23.0) will be studied on varying doses of hydrocortisone replacement therapy. THis is not a new medication for these patients.10 healthy male volunteers will be studied as control subjects. They will NOT receive hydrocortisone.
MedDRA version: 9.1;Level: LLT;Classification code 10021067;Term: Hypopituitarism
MedDRA version: 9.1;Classification code 10033662;Term: Panhypopituitarism
MedDRA version: 9.1;Classification code 10057217;Term: Isolated ACTH deficiency
Trade Name: Hydrocortone
INN or Proposed INN: Hydrocortisone
INN or Proposed INN: Hydrocortisone
Amar AghaNULLAuthorised-recruitment may be ongoing or finishedFemale: no
Male: yes
20Ireland
2EUCTR2004-002056-34-GB
(EUCTR)
10/11/200417/02/2005Glucocorticosteroid replacement therapy and fibrinolysis in hypopituitarism - Glucocorticoid replacement therapy and fibrinolysisGlucocorticosteroid replacement therapy and fibrinolysis in hypopituitarism - Glucocorticoid replacement therapy and fibrinolysis HypopituitarismTrade Name: Hydrocortone
Product Name: Hydrocortone
Product Code: N/A
Trade Name: Hydrocortone
Product Name: Hydrocortone
Product Code: N/A
Bradford Teaching Hospitals NHS Foundation TrustNULLNot Recruiting Female: yes
Male: yes
15 Human pharmacology (Phase 1): Therapeutic exploratory (Phase 2): Therapeutic confirmatory - (Phase 3): Therapeutic use (Phase 4): yesUnited Kingdom